Shareholder Information

Shares In Issue

The number of ordinary shares of the Company in issue is 158,166,666, with approximately 34% deemed to be in public hands.

Significant Shareholders

The Company has been notified of the following interests of 5% or more in the issued ordinary share capital of the Company

  Number Ordinary Shares %
OptiBiotix 53,533,333 33.85%
Holdingselskabet of 29. Juni 2010 Aps. 33,160,000 20.97%
Seneca Partners Limited 8,025,450 5.07%

Directors' Shareholders

  Number Ordinary Share %
Stephen O'Hara 6,131,450 3.88%
Frederik Bruhn-Petersen 3,000,000 1.90%
Adam Reynolds 192,857 0.06%
Steen Andersen 125,450 0.04%

Restrictions on transfer of the Company's Securities

There are no restrictions on the transfer of ProBiotix Health plc's Aquis Exchange securities.

UK City Code on Takeovers and Mergers

ProBiotix Health plc is subject to the UK City Code on Takeovers and Mergers.

Other exchanges and trading platforms

ProBiotix Health plc has not applied or agreed to have any of it securities (including its Aquis Exchange securities) admitted or traded on any other exchanges or trading platforms.

Shareholder Circulars

Date Document
01 July 2025 Proxy Results for the AGM held on 27 June 2025
   
30 May 2025 Notice of Annual General Meeting held on 27 June 2025
  Form of Proxy for the Annual General Meeting held on 27 June 2025
   
15 October 2024 Notice of Requisitioned General Meeting held on 01 November 2024
   
08 August 2024 Proxy results for the AGM held on 08 August 2024
   
28 June 2024 Notice of Annual General Meeting held on 8 August 2024
   
26 July 2023 Proxy results for the AGM held on 26 July 2023
   
28 June 2023 Notice of Annual General Meeting held on 26 July 2023
  Proxy for the Annual General Meeting held on 26 July 2023